BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 26, 2003
View Archived Issues
Two cases of OCD behavior described in children after receiving risperidone
Read More
Beneficial effects reported for FR-167653 in experimental autoimmune myocarditis
Read More
Local methotrexate reported to inhibit tumor progression in mice
Read More
High remission rates obtained with sertraline in OCD
Read More
Good toxicity profile reported for squalamine in patients with solid tumors
Read More
FDA accepts resubmission of Emsam NDA
Read More
Selective agonists of thyroid hormone receptors may have utility in obesity
Read More
Phase I/II trials cleared for topical PTH (7-34) in chemotherapy-induced alopecia
Read More
German permits for 1D09C3 pave way for E.U. clinical trials
Read More
AD-237 enters phase IIa study for COPD
Read More
New joint venture to develop bioresorbable drug-eluting cardiovascular stent
Read More
Novel HCV NS5B inhibitors prepared and tested at GSK
Read More
Novel MCH receptor modulators under study at Neurogen
Read More
Bayer team presents new Rho kinase inhibitors in recent patent
Read More
New IMPDH inhibitors and their use in psoriasis, arthritis and transplant rejection
Read More
New LXR modulators in Pharmacia development pipeline
Read More
Cytochroma discovers new retinoic acid metabolizing cytochrome P450
Read More
Canadian approval for initiation of Actipore trial
Read More
Effect of DN-101 on chemotherapy for NSCLC evaluated in new phase I/II trial
Read More
Approvable letter for Zometa for patients with bone metastases from advanced cancer
Read More
Approval for pediatric extension of Fludara
Read More